Skip to main content
Not investment advice. Educational platform. See Disclaimer.
OTC: GTHP

Guided Therapeutics, Inc.

Healthcare | Medical - Devices
$0.30
Market Cap$30M
Volume54.7K
EPS (TTM)$-0.04

Guided Therapeutics, Inc. (OTC: GTHP) is a $30M medical - devices company trading at $0.30. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:45 UTC.

What Guided Therapeutics, Inc. does

Guided Therapeutics is a medical technology company that develops and markets the LuViva Advanced Cervical Scan, a non-invasive cervical cancer detection device that uses biophotonics—analyzing reflected and fluorescent light—to identify cervical cancers and precancers painlessly at the point of care. The company targets two markets: developing countries where traditional screening infrastructure is limited or absent, and developed countries where LuViva serves as a triage tool to reduce false positives and unnecessary follow-up tests after initial screening.

Summarized from Guided Therapeutics, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$0.30
Market cap$30M
Volume54.7K shares
Valuation
EPS (TTM)$-0.04

Revenue, margins & earnings

FY2021: net loss $2M on revenue $81,000$81,000FY2021FY2022: net loss $4M on revenue $13,000$13,000FY2022FY2023: net loss $3M on revenue $98,000$98,000FY2023FY2024: net loss $2M on revenue $7,000$7,000FY2024FY2025: net loss $3M on revenue $767,000$767,000FY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-05-05
Most recent filed transactions — May 2026:
  • 2026-05-05DirectorOther-88—
  • 2026-05-05DirectorReturned to company-1,000,000—
  • 2026-05-05DirectorOption exercise-1,000,000$200.0K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
No 13F filings reference GTHP in the last quarter.
Source: SEC EDGAR · Last checked 2026-10-11
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Guided Therapeutics, Inc. do?

Guided Therapeutics, Inc. is a medical - devices company, listed on OTC as GTHP.

What is GTHP's valuation?

GTHP trades at $0.30, as of 2026-10-11.

When did GTHP last file with the SEC?

Guided Therapeutics, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-13. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:45 UTC. This page is also available as JSON at /api/data?ticker=GTHP and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for GTHP and 5,000+ tickers.

Create a free account — keep GTHP
For your agent
GET /api/data?ticker=GTHP

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt